Structure-activity relationship study of amphipathic antimicrobial peptides using helix-destabilizing sarcosine
- PMID: 34164880
- DOI: 10.1002/psc.3360
Structure-activity relationship study of amphipathic antimicrobial peptides using helix-destabilizing sarcosine
Abstract
Antimicrobial peptides (AMPs) are potential therapeutic agents against bacteria. We recently showed that a rationally designed AMP, termed Stripe, with an amphipathic distribution of native cationic and hydrophobic amino acids on its helical structure exhibited potent antimicrobial activity against Gram-positive and Gram-negative bacteria with negligible hemolytic activity and cytotoxicity. In this study, the structure-activity relationship of Stripe was elucidated by designing a series of antimicrobial peptides whereby amino acid residues of Stripe were exchanged with helix-destabilizing sarcosine residues. Stripe 1-5 peptides with hydrophobic amino acids substituted with sarcosine were predominantly unstructured and showed no antimicrobial activity, except against Escherichia coli (E. coli) (DH5α) cells. The activity against E. coli (DH5α) cells and the helicity of Stripe 1-5 peptides decreased concomitantly as the number of sarcosine residue substitutions increased. Stripe 1-5 peptides showed no hemolytic activity or cytotoxicity. The results indicate that sarcosine substitutions provide an approach to study the structure-activity relationship of helical AMPs, and the helicity of Stripe is an important feature defining its activity.
Keywords: amphipathicity; antimicrobial peptides; helical structures; sarcosine.
© 2021 European Peptide Society and John Wiley & Sons, Ltd.
References
REFERENCES
-
- Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov. 2011;11(1):37-51.
-
- Spohn R, Daruka L, Lázár V, et al. Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance. Nat Commun. 2019;10:4538
-
- Bahar AA, Ren D. Antimicrobial Peptides. Antimicrobial Peptides Pharmaceuticals. 2013;6(12):1543-1575.
-
- Hancock REW, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24(12):1551-1557.
-
- Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389-395.
MeSH terms
Substances
Grants and funding
- 20mk0101120j0003 to Y.D./Japan Agency for Medical Research and Development
- KAKENHI, Grants 18H05502 to Y.D./Japan Society for the Promotion of Science
- KAKENHI, Grants 18k14880 to T.M./Japan Society for the Promotion of Science
- KAKENHI, Grants 20k22711 to H.Y./Japan Society for the Promotion of Science
- The Kobayashi Foundation for Cancer Research to Y.D.